Abstract:Rationale: Mitochondria are important cellular organelles and play essential roles in maintaining cell structure and function. Emerging evidence indicates that in addition to having proinflammatory and proapoptotic effects, TNFα (tumor necrosis factor α) can, under certain circumstances, promote improvements in mitochondrial integrity and function, phenomena that can be ascribed to the existence of TNFR2 (TNFα receptor 2). Objective: The present study aimed to investigate whether and how TNFR2 activation mediates the effects of TNFα on mitochondria. Methods and Results: Freshly isolated neonatal mouse cardiac myocytes treated with shRNA targeting TNFR1 were used to study the effects of TNFR2 activation on mitochondrial function. Neonatal mouse cardiac myocytes exhibited increases in mitochondrial fusion, a change that was associated with increases in mitochondrial membrane potential, intracellular ATP levels, and oxygen consumption capacity. Importantly, TNFR2 activation–induced increases in OPA1 (optic atrophy 1) protein expression were responsible for the above enhancements, and these changes could be attenuated using siRNA targeting OPA1. Moreover, both Stat3 and RelA bound to the promoter region of OPA1 and their interactions synergistically upregulated OPA1 expression at the transcriptional level. Stat3 acetylation at lysine 370 or lysine 383 played a key role in the ability of Stat3 to form a supercomplex with RelA. Meanwhile, p300 modulated Stat3 acetylation in HEK293T (human embryonic kidney 293T) cells, and p300-mediated Stat3/RelA interactions played an indispensable role in OPA1 upregulation. Finally, TNFR2 activation exerted beneficial effects on OPA1 expression in an in vivo transverse aortic constriction model, whereby TNFR1-knockout mice exhibited better outcomes than in mice with both TNFR1 and TNFR2 knocked out. Conclusions: TNFR2 activation protects cardiac myocytes against stress by upregulating OPA1 expression. This process was facilitated by p300-mediated Stat3 acetylation and Stat3/RelA interactions, leading to improvements in mitochondrial morphology and function.

OPA1-Exon4b Binds to Mtdna D-Loop for Transcriptional and Metabolic Modulation, Independent of Mitochondrial Fusion

OPA1 supports mitochondrial dynamics and immune evasion to CD8+ T cell in lung adenocarcinoma

ATAD3B is a Mitophagy Receptor Mediating Clearance of Oxidative Stress‐induced Damaged Mitochondrial DNA

TNFR 2 Stimulation Promotes Mitochondrial Fusion Via Stat 3-and NF-kB – Dependent Activation of OPA 1 Expression

Opa1 Haploinsufficiency Due To A Novel Splicing Variant Resulting In Mitochondrial Dysfunction Without Mitochondrial Dna Depletion

OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution

OPA1, a molecular regulator of dilated cardiomyopathy

OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response

Mitochondrial membrane potential and oxidative stress interact to regulate Oma1-dependent processing of Opa1 and mitochondrial dynamics

OPA1 mediates cardiac function and metabolism: in silico and in vivo evidence

and disease-causing mutants perturb mitochondrial nucleoid distribution

Differentiation activates mitochondrial OPA1 processing in myoblast cell lines

Chchd2 Regulates Mitochondrial Morphology by Modulating the Levels of Opa1

47-OR: OPA1 Reprograms Macrophage Metabolism to Enforce Tolerance of Inflammation in Obesity

OPA1 Modulates Mitochondrial Ca2+ Uptake Through ER-Mitochondria Coupling

The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission

OLA1 Phosphorylation Governs the Mitochondrial Bioenergetic Function of Pulmonary Vascular Cells

Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation

OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development

Cryo-EM structures reveal interactions of S-OPA1 with membrane and changes upon nucleotide binding

Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy